United States · Health Care · USD · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average (own scale)
Sector average
Amounts in USD; stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Pharmagreen Biotech Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| ROE | 7.74% | 8.03% | 7.51% | 8.11% | 8.91% | 10.57% |
|---|---|---|---|---|---|---|
| Sector average | 22.99% | 73.17% | 65.88% | 68.36% | 41.61% | 44.34% |
| ROA | -116.12% | -124.32% | -117.49% | -118.27% | -121.81% | -145.15% |
| Gross Margin | 34.84% | 38.12% | 34.3% | 30.87% | 27.79% | 25.01% |
| Sector average | 45.84% | 46.72% | 46.7% | |||
| Total Assets | $140,313.00 | $143,023.72 | $159,792.47 | $191,448.04 | $216,989.24 | $231,394.94 |
| Net Income | -$162,931.00 | -$176,126.95 | -$177,888.53 | -$207,704.83 | -$248,760.49 | -$325,408.43 |
| 45.37% |
| 44.33% |
| 43.24% |